Welcome to Markets Desk, your midday read on what's moving markets and policy.
Hedge funds now hold a record share of the thirty trillion dollar Treasury market, and the question on every risk desk is what happens when the tide turns. Their growing presence can add liquidity in calm conditions, but the leverage embedded in those positions means a disorderly unwind could ripple hard through sovereign debt markets worldwide.
Shifting to equities, Vanda Pharmaceuticals is catching a bid today after the company reported positive topline results from a Phase Three trial of HETLIOZ in adults with Delayed Sleep-Wake Phase Disorder. Meeting the primary endpoint in a Phase Three study is a meaningful clinical milestone, and the market is rewarding it with a sharp move higher in the stock.
And on the policy front, Health Secretary Robert F. Kennedy Junior used a public platform to argue that artificial intelligence is better equipped than doctors to deliver second opinions, calling it a path to freeing Americans from what he termed medical tyranny. The comments are already drawing scrutiny from health professionals and reigniting the debate over AI's role in clinical decision-making.
That's the tape. Markets Desk, signing off the floor.
